Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Gastric Bypass Market

ID: MRFR/MED/15158-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US Gastric Bypass Market Research Report By Type (Endoscopic Sleeve Gastroplasty, Intragastric Balloon), By Indication (Gastroesophageal Reflux Disease, Heart Disease, Type 2 Diabetes) and By End User (Hospitals, Surgical Centers) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Gastric Bypass Market Infographic
Purchase Options

US Gastric Bypass Market Summary

As per Market Research Future analysis, the US gastric bypass market size was estimated at 0.653 USD Million in 2024. The US gastric bypass market is projected to grow from 0.691 USD Million in 2025 to 1.21 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US gastric bypass market is experiencing a transformative shift driven by technological advancements and rising health awareness.

  • Technological advancements in surgical techniques are enhancing the efficacy and safety of gastric bypass procedures.
  • Increased awareness of obesity-related health risks is driving more individuals to seek surgical weight loss solutions.
  • The evolving insurance coverage and reimbursement policies are facilitating greater access to gastric bypass surgeries.
  • Rising obesity rates and advancements in surgical technology are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 0.653 (USD Million)
2035 Market Size 1.21 (USD Million)
CAGR (2025 - 2035) 5.8%

Major Players

Johnson & Johnson (US), Medtronic (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Ethicon (US), Intuitive Surgical (US), Conmed Corporation (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Gastric Bypass Market Trends

The gastric bypass market is currently experiencing notable shifts driven by various factors, including advancements in surgical techniques and increasing awareness of obesity-related health issues. As healthcare providers adopt minimally invasive procedures, patient outcomes appear to improve, leading to heightened interest among individuals seeking weight loss solutions. Furthermore, the rising prevalence of obesity in the United States has prompted a greater focus on effective interventions, with gastric bypass surgery emerging as a viable option for many. This trend is likely to continue as more patients recognize the potential benefits of surgical weight loss, including improved quality of life and reduced risk of comorbidities. In addition, the gastric bypass market is influenced by evolving insurance policies and reimbursement practices. Insurers are increasingly covering bariatric procedures, which may enhance accessibility for patients. This shift could lead to a broader demographic seeking surgical options, as financial barriers diminish. Moreover, ongoing research into the long-term effects of gastric bypass surgery suggests that patient education and support systems are crucial for successful outcomes. As the market evolves, stakeholders must remain attuned to these dynamics to effectively address the needs of patients and healthcare providers alike.

Technological Advancements in Surgical Techniques

Recent innovations in surgical methods are transforming the gastric bypass market. Minimally invasive techniques, such as laparoscopic surgery, are becoming more prevalent, resulting in shorter recovery times and reduced complications. These advancements may encourage more patients to consider surgical options, as they offer a less daunting approach to weight loss.

Increased Awareness of Obesity-Related Health Risks

There is a growing recognition of the health risks associated with obesity, including diabetes, heart disease, and certain cancers. This awareness is driving individuals to seek effective weight loss solutions, with gastric bypass surgery being viewed as a viable option. As public health campaigns continue to highlight these risks, demand for surgical interventions may rise.

Evolving Insurance Coverage and Reimbursement Policies

Changes in insurance coverage for bariatric procedures are impacting the gastric bypass market. As more insurers begin to cover these surgeries, financial barriers for patients are likely to decrease. This trend could lead to an increase in the number of individuals pursuing gastric bypass as a weight loss solution.

US Gastric Bypass Market Drivers

Rising Obesity Rates

The increasing prevalence of obesity in the US is a primary driver for the gastric bypass market. According to the CDC, approximately 42.4% of adults were classified as obese in 2017-2018, a figure that has likely risen. This alarming trend has led to a greater demand for surgical interventions, including gastric bypass procedures. As obesity is linked to various comorbidities such as diabetes, hypertension, and cardiovascular diseases, the urgency for effective weight-loss solutions has intensified. The gastric bypass market is responding to this need by expanding its offerings and improving surgical outcomes. Furthermore, the economic burden of obesity, estimated at $147 billion annually, underscores the necessity for effective treatments, thereby propelling the market forward.

Evolving Patient Demographics

The evolving demographics of patients seeking gastric bypass surgery are influencing the market dynamics. An increasing number of younger individuals, including adolescents, are being diagnosed with obesity, prompting a shift in the target demographic for the gastric bypass market. This trend indicates a need for tailored surgical solutions that address the unique challenges faced by younger patients. Additionally, the growing diversity in the patient population necessitates culturally competent care and consideration of varying health beliefs. The gastric bypass market must adapt to these changing demographics by offering personalized treatment plans and support systems. As more individuals from diverse backgrounds seek surgical options, the market is likely to expand, reflecting the need for inclusive healthcare solutions.

Advancements in Surgical Technology

Technological innovations in surgical techniques are significantly influencing the gastric bypass market. Minimally invasive procedures, such as laparoscopic gastric bypass, have gained traction due to their reduced recovery times and lower complication rates. The introduction of robotic-assisted surgeries further enhances precision and patient outcomes. As these technologies become more accessible, the gastric bypass market is likely to experience increased adoption rates among healthcare providers. Moreover, the integration of advanced imaging techniques and surgical simulations is expected to improve preoperative planning and postoperative care. This evolution in surgical technology not only enhances patient safety but also contributes to the overall growth of the gastric bypass market, as more patients seek these advanced treatment options.

Growing Demand for Weight Loss Solutions

The rising demand for effective weight loss solutions is a crucial driver for the gastric bypass market. With a significant portion of the population struggling with obesity, many individuals are turning to surgical options as a viable alternative to traditional weight loss methods. The gastric bypass market is witnessing an increase in patient inquiries and consultations, reflecting a shift in attitudes towards surgical interventions. Additionally, the success rates associated with gastric bypass procedures, which can lead to substantial weight loss and improvement in obesity-related conditions, are encouraging more patients to consider this option. As awareness of the benefits of surgical weight loss continues to grow, the market is poised for further expansion.

Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare is shaping the landscape of the gastric bypass market. As healthcare providers and policymakers prioritize preventive measures, there is a heightened awareness of the long-term health implications of obesity. This shift is prompting more individuals to seek surgical interventions as a proactive approach to managing their weight and associated health risks. The gastric bypass market is likely to benefit from this trend, as patients increasingly view surgery as a means to prevent serious health issues rather than merely a cosmetic procedure. Furthermore, the integration of weight management programs and lifestyle modifications alongside surgical options is expected to enhance patient outcomes and satisfaction, thereby driving market growth.

Market Segment Insights

By Type: Endoscopic Sleeve Gastroplasty (Largest) vs. Intragastric Balloon (Fastest-Growing)

The US gastric bypass market shows a significant distribution of market share between Endoscopic Sleeve Gastroplasty and Intragastric Balloon. Currently, Endoscopic Sleeve Gastroplasty dominates the market due to its minimally invasive nature and effectiveness in weight loss, capturing the largest share. In contrast, the Intragastric Balloon is gaining traction, appealing to patients looking for non-surgical alternatives, thus carving out a considerable market presence. Looking ahead, the growth trends indicate a favorable shift towards non-surgical options, with the Intragastric Balloon emerging as the fastest-growing segment. This growth is driven by increasing awareness of obesity-related health issues and the rising demand for less invasive procedures. Furthermore, technological advancements and marketing efforts have bolstered the accessibility and appeal of these alternatives in the market.

Endoscopic Sleeve Gastroplasty (Dominant) vs. Intragastric Balloon (Emerging)

Endoscopic Sleeve Gastroplasty is recognized as the dominant player in the US gastric bypass market, offering a highly effective, minimally invasive solution for weight loss. Its innovative approach has led to significant patient satisfaction and lower risk of complications compared to traditional surgical methods. On the other hand, the Intragastric Balloon represents an emerging option, gaining popularity among individuals hesitant to undergo surgery. This segment is characterized by its reversible nature and lower upfront costs, appealing to a broader demographic. As both treatment options continue to evolve, they provide patients with more choices tailored to their health needs and goals.

By Indication: Obesity (Largest) vs. Type 2 Diabetes (Fastest-Growing)

The US gastric bypass market showcases a diverse indication segment, with obesity dominating the market share. This condition accounts for a significant majority of procedures, reflecting the high prevalence of obesity across various demographics. Other indications, such as gastroesophageal reflux disease, heart disease, and high blood pressure, also contribute to the market but to a lesser extent, indicating a concentrated focus on obesity in surgical interventions. Growth trends within this segment are driven by increasing awareness of obesity-related health issues and the effectiveness of gastric bypass surgery in achieving long-term weight loss. Additionally, the rising incident rates of type 2 diabetes have made it an emerging focus area within this segment, propelling demand for gastric bypass as a viable solution for managing insulin resistance and associated metabolic disorders.

Obesity: Dominant vs. Type 2 Diabetes: Emerging

Obesity represents the dominant indication in the US gastric bypass market, characterized by its significant impact on overall health and increasing rates in various age groups. The overwhelming demand for surgical options stems from the urgent need to address severe obesity and its comorbidities, such as heart disease and type 2 diabetes. In contrast, type 2 diabetes is emerging as a critical indication due to its strong correlation with obesity and the rising trends in diabetes prevalence. As more patients seek surgical intervention for weight loss to combat insulin resistance, the role of gastric bypass in managing diabetes is becoming increasingly recognized, leading to a rise in surgical candidates driven by this condition.

By End User: Hospitals & Clinics (Largest) vs. Surgical Centers (Fastest-Growing)

In the US gastric bypass market, Hospitals & Clinics hold the largest share, primarily due to their comprehensive service offerings and established reputations. These facilities are preferred by patients seeking reliable surgical interventions, leading to a significant portion of the market being captured by them. On the other hand, Surgical Centers, while smaller in market share, have been gaining traction due to their specialized services and the increasing demand for outpatient procedures. The growth trends in this segment are heavily influenced by rising obesity rates and an increasing awareness of the benefits associated with gastric bypass surgery. Surgical Centers are experiencing the fastest growth due to advancements in minimally invasive techniques and enhanced recovery protocols. As healthcare systems evolve, there is a notable shift towards faster and more patient-centric surgical options, driving more patients to these specialized centers for their surgical needs.

Hospitals & Clinics (Dominant) vs. Surgical Centers (Emerging)

Hospitals & Clinics are the dominant players in the US gastric bypass market, boasting extensive resources, multi-disciplinary care teams, and comprehensive care pathways that attract a vast patient base. Their ability to offer a full spectrum of post-operative care contributes to their market leadership. Conversely, Surgical Centers are emerging as significant competitors by focusing on specific surgical procedures and offering them at lower costs, fostering an environment that prioritizes patient convenience. These centers are adept at utilizing advanced surgical technologies, which enables faster recovery times, making them a preferred choice for many patients. As healthcare shifts towards more efficient models, the role of Surgical Centers is poised to expand, catering to a growing preference for outpatient surgical solutions.

Get more detailed insights about US Gastric Bypass Market

Key Players and Competitive Insights

The gastric bypass market exhibits a dynamic competitive landscape characterized by rapid innovation and strategic maneuvering among key players. Major companies such as Johnson & Johnson (US), Medtronic (US), and Intuitive Surgical (US) are at the forefront, leveraging their extensive research capabilities and technological advancements to enhance surgical outcomes. Johnson & Johnson (US) focuses on integrating digital health solutions into its surgical platforms, while Medtronic (US) emphasizes the development of minimally invasive techniques. Intuitive Surgical (US) continues to lead in robotic-assisted surgery, which is increasingly becoming a preferred option in gastric bypass procedures. Collectively, these strategies not only enhance patient care but also intensify competition, as companies strive to differentiate themselves through innovation and improved surgical efficacy.Key business tactics within the gastric bypass market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players competing for market share. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive environment encourages smaller firms to innovate and adapt, thereby fostering a culture of continuous improvement and responsiveness to market demands.

In October Medtronic (US) announced the launch of a new line of advanced surgical instruments designed specifically for gastric bypass procedures. This strategic move is significant as it not only expands Medtronic's product portfolio but also reinforces its commitment to enhancing surgical precision and patient safety. By investing in cutting-edge technology, Medtronic aims to capture a larger share of the market and respond to the growing demand for minimally invasive surgical options.

In September Intuitive Surgical (US) unveiled an upgraded version of its robotic surgical system, which includes enhanced imaging capabilities and AI-driven analytics. This development is crucial as it positions Intuitive Surgical to maintain its leadership in robotic-assisted surgeries, particularly in the gastric bypass segment. The integration of AI technology is likely to improve surgical outcomes and streamline the surgical process, thereby attracting more healthcare providers to adopt their systems.

In August Johnson & Johnson (US) entered into a strategic partnership with a leading telehealth provider to enhance pre- and post-operative care for gastric bypass patients. This collaboration is indicative of a broader trend towards digital health integration, which aims to improve patient engagement and outcomes. By focusing on comprehensive care solutions, Johnson & Johnson is likely to strengthen its market position and enhance patient satisfaction, which is increasingly becoming a critical factor in healthcare delivery.

As of November the competitive trends in the gastric bypass market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a pivotal role in shaping the landscape, as companies seek to combine their strengths to deliver innovative solutions. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in navigating the complexities of the gastric bypass market.

Key Companies in the US Gastric Bypass Market include

Industry Developments

The US Gastric Bypass Market has seen significant developments recently, with advances in technology and increased patient accessibility driving growth. Companies like Hologic and Medtronic are focusing on innovative surgical instruments and techniques that enhance patient outcomes.

In June 2023, Johnson and Johnson completed its acquisition of a surgical robotics firm, expanding its expertise in minimally invasive procedures, further pushing the capabilities in this market. In July 2023, Boston Scientific showcased new devices aimed at improving long-term weight loss results, highlighting the competitive landscape.

Additionally, Acelity has been investing in R&D to improve wound management post-surgery, which directly impacts recovery times and patient satisfaction. Market valuation for the Gastric Bypass sector has increased significantly, with a notable uptick in demand for personalized treatment options.

In the previous years, particularly in 2021 and 2022, there was notable growth driven by a nationwide increase in obesity rates, pushing more patients toward surgical options. With continual advancements in surgical techniques and equipment, the market is poised for sustained expansion, emphasizing the importance of adaptive strategies by key players like Ethicon, Stryker, and Intuitive Surgical.

Future Outlook

US Gastric Bypass Market Future Outlook

The Gastric Bypass Market is projected to grow at a 5.8% CAGR from 2025 to 2035, driven by increasing obesity rates, technological advancements, and rising healthcare expenditure.

New opportunities lie in:

  • Expansion of telehealth services for pre- and post-operative care
  • Development of minimally invasive surgical techniques
  • Partnerships with insurance providers for better coverage options

By 2035, the gastric bypass market is expected to achieve robust growth and enhanced service offerings.

Market Segmentation

US Gastric Bypass Market Type Outlook

  • Endoscopic Sleeve Gastroplasty
  • Intragastric Balloon

US Gastric Bypass Market End User Outlook

  • Hospitals & Clinics
  • Surgical Centers
  • Others

US Gastric Bypass Market Indication Outlook

  • Obesity
  • Gastroesophageal Reflux Disease
  • Heart Disease
  • High Blood Pressure
  • Type 2 Diabetes
  • Others

Report Scope

MARKET SIZE 2024 0.653(USD Million)
MARKET SIZE 2025 0.691(USD Million)
MARKET SIZE 2035 1.21(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.8% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Johnson & Johnson (US), Medtronic (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Ethicon (US), Intuitive Surgical (US), Conmed Corporation (US)
Segments Covered Type, Indication, End User
Key Market Opportunities Emerging minimally invasive techniques enhance patient outcomes in the gastric bypass market.
Key Market Dynamics Rising demand for minimally invasive procedures drives innovation and competition in the gastric bypass market.
Countries Covered US
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Leave a Comment

FAQs

What was the market valuation of the US gastric bypass market in 2024?

The market valuation was $0.653 Million in 2024.

What is the projected market valuation for the US gastric bypass market in 2035?

The projected valuation for 2035 is $1.21 Million.

What is the expected CAGR for the US gastric bypass market during the forecast period 2025 - 2035?

The expected CAGR is 5.8% during the forecast period 2025 - 2035.

Which companies are considered key players in the US gastric bypass market?

Key players include Johnson & Johnson, Medtronic, Boston Scientific, Stryker, B. Braun Melsungen AG, Ethicon, Intuitive Surgical, and Conmed Corporation.

What are the main types of procedures in the US gastric bypass market?

The main types include Endoscopic Sleeve Gastroplasty and Intragastric Balloon.

What was the market size for Endoscopic Sleeve Gastroplasty in 2024?

The market size for Endoscopic Sleeve Gastroplasty was $0.4 Million in 2024.

What is the projected market size for Intragastric Balloon by 2035?

The projected market size for Intragastric Balloon is $0.46 Million by 2035.

What indications are driving the US gastric bypass market?

Indications include Obesity, Gastroesophageal Reflux Disease, Heart Disease, High Blood Pressure, and Type 2 Diabetes.

What was the market size for hospitals and clinics in the US gastric bypass market in 2024?

The market size for hospitals and clinics was $0.392 Million in 2024.

What is the expected market size for surgical centers by 2035?

The expected market size for surgical centers is $0.392 Million by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions